Clarity Pharmaceuticals Ltd – 25 August 2021 #
| Listing date | 25 August 2021 # |
| Contact details | https://www.claritypharmaceuticals.com/ Ph: +61 2 9209 4037 |
| Principal Activities | Clarity is a clinical stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. |
| GICS industry group | TBA |
| Issue Price | $1.40 |
| Issue Type | Ordinary Fully Paid Shares |
| Security code | CU6 |
| Capital to be Raised | $92,000,000 |
| Expected offer close date | 10 August 2021 |
| Underwriter | Fully underwritten. Jefferies (Australia) Pty Ltd and Bell Potter Securities Limited (Joint Underwriters and Lead Managers) |
